Xenon Pharmaceuticals Inc...

NASDAQ: XENE · Real-Time Price · USD
38.23
0.27 (0.71%)
At close: Aug 15, 2025, 3:59 PM
38.23
0.00%
After-hours: Aug 15, 2025, 04:42 PM EDT

Xenon Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a 9.43M 18.44M
Cost of Revenue
2.56M 167.51M 105.77M 75.46M
Gross Profit
n/a -167.51M -96.33M -57.03M
Operating Income
-279.3M -214.05M -129.14M -78.99M
Interest Income
41.94M 27.62M 8.71M 466K
Pretax Income
-238.42M -182.69M -125.25M -78.89M
Net Income
-234.33M -182.39M -125.37M -78.88M
Selling & General & Admin
68.9M 46.54M 32.81M 21.97M
Research & Development
210.39M 167.51M 105.77M 75.46M
Other Expenses
n/a -167.51M 3.89M 105K
Operating Expenses
279.3M 46.54M 138.58M 97.43M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 214.05M 138.58M 97.43M
Income Tax Expense
-4.09M -292K 118K -6K
Shares Outstanding (Basic)
77.89M 66.89M 60.54M 43.63M
Shares Outstanding (Diluted)
77.89M 66.89M 60.54M 43.63M
EPS (Basic)
-3.01 -2.73 -2.07 -1.81
EPS (Diluted)
-3.01 -2.73 -2.07 -1.81
EBITDA
-235.86M -210.51M -127.52M -78.09M
EBIT
-238.42M -214.05M -129.14M -78.99M
Depreciation & Amortization
2.56M 3.54M 1.62M 906K